Prevention of premature birth in pregnant women with vaginal candidiasis

Candida vulvovaginitis is an infectious lesion of the vulvar and vaginal mucosa caused by Candida yeast fungi. Vaginal candidiasis during pregnancy is associated with spontaneous miscarriages, premature rupture of the fetal membranes, premature birth, and low birth weight babies. Considering the potential risk of premature delivery at fungal invasion at the level of the lower reproductive tract of a pregnant woman, the search for a complex of preventive measures and timely treatment of сandida vulvovaginitis during gestation is of particular interest. The article presents the results of the use of the drug Zalain in 36 pregnant women, with a gestation period of 28 weeks or more with acute candidal vulvaginitis. In the course of the work, the results of local therapy with Zalain were evaluated and its clinical efficacy in the prevention of preterm labor was confirmed. The results of treatment contribute to a significant reduction in the frequency of initiation of preterm labor, as well as a persistent effect for 2-4 weeks after completion of the course in the postpartum period and the absence of early and distant manifestations of candidiasis in newborns.

candidal vaginitis, preterm labor, vaginal microbiocenosis, Candida fungi, Zalain, antimycotic drugs

1. Chew S.Y., Than L.T. Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches. Mycoses. 2016 May;59(5):262-73. doi: 10.1111/myc.12455.

2. Gonçalves B., Ferreira C., Alves C.T., Henriques M., Azeredo J., Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016 Nov;42(6):905-27. doi: 10.3109/1040841X.2015.1091805.

3. Paladine H.L., Desai U.A. Vaginitis: Diagnosis and Treatment. Am Fam Physician. 2018 Mar 1;97(5):321-329.

4. Стрижаков А.Н., Белоцерковцева Л.Д., Буданов П.В. Системный подход к выбору клинического решения при вульвовагинальных инфекциях. Вопросы гинекологии, акушерства и перинатологии. 2014;13(1):60-66. [Strizhakov A.N., Belotserkovtseva L.D., Budanov P.V. A systematic approach to choosing a clinical solution for vulvovaginal infections. Voprosy Ginekologii, Akusherstva i Perinatologii. 2014;13(1):60-66.] (In Russ).

5. Novakov Mikic A., Stojic S. Study results on the use of different therapies for the treatment of vaginitis in hospitalized pregnant women. Arch Gynecol Obstet. 2015 Feb5.

6. Khan M., Ahmed J., Gul A., Ikram A., Lalani F.K. Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infect Drug Resist. 2018 Mar 28;11:447-456. doi: 10.2147/IDR.S153116.

7. Mtibaa L., Fakhfakh N., Kallel A., Belhadj S., Belhaj Salah N., Bada N., Kallel K. Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. J Mycol Med. 2017 Jun;27(2):153-158. doi: 10.1016/j.mycmed.2017.01.003.

8. Mucci M.J., Cuestas M.L., Cervetto M.M., Landaburu M.F., Mujica M.T. A prospective observational study of vulvovagintis in pregnant women in Argentina, with special reference to candidiasis. Mycoses. 2016 Jul;59(7):429-35. doi: 10.1111/myc.12490.

9. Tellapragada C., Eshwara V.K., Bhat P., Kamath A., Aletty S., Mukhopadhyay C. Screening of vulvovaginal infections during pregnancy in resource constrained settings: Implications on preterm delivery. J Infect Public Health. 2017 JulAug;10(4):431-437. doi: 10.1016/j.jiph.2016.06.003.

10. Zisova L.G., Chokoeva A.A., Amaliev G.I., Petleshkova P.V., Miteva-Katrandzhieva T.М., Krasteva M.B., Uchikova E.H., Kouzmanov A.H., Ivanova Z.V. Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns. Folia Med (Plovdiv). 2016 Apr-Jun;58(2):108-14. doi: 10.1515/folmed-2016-0018.

11. Rotem R., Fishman B., Daniel S., Koren G., Lunenfeld E., Levy A. Risk of major congenital malformations following first-trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population-based retrospective cohort study. BJOG. 2018 Nov;125(12):1550-1556. doi: 10.1111/1471-0528.15293. Epub 2018 Jun 25.

12. Прилепская В.Н., Межевитина Е.А., Абакарова П.Р., Бровкина Т.В., Погосян Ш.М. Лечение вульвовагинитов и вагинозов: клинико-лабораторная эффективность. Гинекология. 2013;15(4):4-9. [Prilepskaya V.N., Mezhevitina E.A., Abakarova P.R., Brovkina T.V., Pogosyan Sh.M. Treatment of vulvovaginitis and vaginosis: clinical and laboratory efficacy. Ginekologiya. 2013;15(4):4-9.] (In Russ).

13. Аполихина И.А., Горбунова Е.А., Додова Е.Г., Гасанова Г.Ф. Современные аспекты комбинированной антибактериальной терапии неспецифического вагинита и цервицита (результаты неинтервенционного исследования BALANCE*). Акушерство и гинекология. 2015;8:1-8. [Apolikhina I.A., Gorbunova E.A., Dodova E.G., Gasanova G.F. Current aspects of combination antibiotic therapy for nonspecific vaginitis and cervicitis (results of the non-interventional BALANCE* study). Akusherstvo i Ginekologiya. 2015;8:1-8.] (In Russ).

14. Сухих Г.Т. Трофимов Д.Ю., Буремнская О.В., Байрамова Г.Р., Непша О.С., Донников А.Е., Дуринян Э.Р., Бирюкова А.М. Профиль экспрессии цитокинов в вагинальных мазках женщин репродуктивного возраста при неспецифическом вагините и бактериальном вагинозе. Акушерство и гине-кология. 2011;7-2:33-38. [Sukhikh G.T., Trofimov D.Yu., Buremnskaya O.V., Bayramova G.R., Nepsha, O.S., Donnikov A.E., Durinyan E.R., Biryukova A.M. Cytokines expression profile in the vaginal smears of reproductive age women in non-specific vaginitis and bacterial vaginosis. Akusherstvo i Ginekologiya. 2011;7-2:33-38.] (In Russ).

15. Стрижаков А.Н., Буданов П.В. Лечение вульвовагинальных инфекций с позиций доказательной медицины. Вопросы гинекологии, акушерства и перинатологии. 2015;14(1):69-74. [Strizhakov A.N., Budanov P.V. Treatment of vulvovaginal infections from the perspective of evidence-based medicine. Voprosy Ginekologii, Akusherstva i Perinatologii. 2015;14(1):69-74.] (In Russ).

16. Yu F., Tang Y.T., Hu Z.Q., Lin X.N. Analysis of the Vaginal Microecological Status and Genital Tract Infection Characteristics of 751 Pregnant Women. Med Sci Monit. 2018 Aug 1;24:5338-5345. doi: 10.12659/MSM.909051.

17. Grigsby P.L. et al. Choriodecidual inflammation: a harbinger of the preterm labor syndrome. Reprod Sci. 2010;17(1):85–94.

18. Veleminsky M.J. et al. Relationship of amniotic-type placenta inflammation to pPROM, PROM and risk of early onset neonatal sepsis. Neuro Endocrinol Lett. 2008;29(4):447–450.

19. Shah R., Verma P.K. Therapeutic importance of synthetic thiophene. Chem Cent J. 2018 Dec 19;12(1):137. doi: 10.1186/s13065-018-0511-5.